Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

334 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research.
Hamadani M, Saber W, Ahn KW, Carreras J, Cairo MS, Fenske TS, Gale RP, Gibson J, Hale GA, Hari PN, Hsu JW, Inwards DJ, Kamble RT, Klein A, Maharaj D, Marks DI, Rizzieri DA, Savani BN, Schouten HC, Waller EK, Wirk B, Lazarus HM. Hamadani M, et al. Among authors: hari pn. Biol Blood Marrow Transplant. 2013 Apr;19(4):625-31. doi: 10.1016/j.bbmt.2013.01.009. Epub 2013 Jan 17. Biol Blood Marrow Transplant. 2013. PMID: 23333532 Free PMC article.
Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia.
Anagnostopoulos A, Hari PN, Pérez WS, Ballen K, Bashey A, Bredeson CN, Freytes CO, Gale RP, Gertz MA, Gibson J, Goldschmidt H, Lazarus HM, McCarthy PL, Reece DE, Vesole DH, Giralt SA. Anagnostopoulos A, et al. Among authors: hari pn. Biol Blood Marrow Transplant. 2006 Aug;12(8):845-54. doi: 10.1016/j.bbmt.2006.04.010. Biol Blood Marrow Transplant. 2006. PMID: 16864055 Free article.
Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning.
Hari P, Carreras J, Zhang MJ, Gale RP, Bolwell BJ, Bredeson CN, Burns LJ, Cairo MS, Freytes CO, Goldstein SC, Hale GA, Inwards DJ, Lemaistre CF, Maharaj D, Marks DI, Schouten HC, Slavin S, Vose JM, Lazarus HM, van Besien K. Hari P, et al. Biol Blood Marrow Transplant. 2008 Feb;14(2):236-45. doi: 10.1016/j.bbmt.2007.11.004. Biol Blood Marrow Transplant. 2008. PMID: 18215784 Free PMC article.
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant.
Smith SM, van Besien K, Carreras J, Bashey A, Cairo MS, Freytes CO, Gale RP, Hale GA, Hayes-Lattin B, Holmberg LA, Keating A, Maziarz RT, McCarthy PL, Navarro WH, Pavlovsky S, Schouten HC, Seftel M, Wiernik PH, Vose JM, Lazarus HM, Hari P. Smith SM, et al. Biol Blood Marrow Transplant. 2008 Aug;14(8):904-12. doi: 10.1016/j.bbmt.2008.05.021. Biol Blood Marrow Transplant. 2008. PMID: 18640574 Free PMC article. Clinical Trial.
Comparison of twin and autologous transplants for multiple myeloma.
Bashey A, Pérez WS, Zhang MJ, Anderson KC, Ballen K, Berenson JR, To LB, Fonseca R, Freytes CO, Gale RP, Gibson J, Giralt SA, Kyle RA, Lazarus HM, Maharaj D, McCarthy PL, Milone GA, Nimer S, Pavlovsky S, Reece DE, Schiller G, Vesole DH, Hari P; Plasma Cell Disorders Working Committee. Bashey A, et al. Biol Blood Marrow Transplant. 2008 Oct;14(10):1118-1124. doi: 10.1016/j.bbmt.2008.07.007. Biol Blood Marrow Transplant. 2008. PMID: 18804041 Free PMC article. Clinical Trial.
Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.
Kumar S, Pérez WS, Zhang MJ, Ballen K, Bashey A, To LB, Bredeson CN, Cairo MS, Elfenbein GJ, Freytes CO, Gale RP, Gibson J, Kyle RA, Lacy MQ, Lazarus HM, McCarthy PL, Milone GA, Moreb JS, Pavlovsky S, Reece DE, Vesole DH, Wiernik PH, Hari P. Kumar S, et al. Biol Blood Marrow Transplant. 2008 Oct;14(10):1134-1140. doi: 10.1016/j.bbmt.2008.07.011. Biol Blood Marrow Transplant. 2008. PMID: 18804043 Free PMC article.
Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
Devetten MP, Hari PN, Carreras J, Logan BR, van Besien K, Bredeson CN, Freytes CO, Gale RP, Gibson J, Giralt SA, Goldstein SC, Gupta V, Marks DI, Maziarz RT, Vose JM, Lazarus HM, Anderlini P. Devetten MP, et al. Among authors: hari pn. Biol Blood Marrow Transplant. 2009 Jan;15(1):109-17. doi: 10.1016/j.bbmt.2008.11.011. Biol Blood Marrow Transplant. 2009. PMID: 19135949 Free PMC article.
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.
Fenske TS, Hari PN, Carreras J, Zhang MJ, Kamble RT, Bolwell BJ, Cairo MS, Champlin RE, Chen YB, Freytes CO, Gale RP, Hale GA, Ilhan O, Khoury HJ, Lister J, Maharaj D, Marks DI, Munker R, Pecora AL, Rowlings PA, Shea TC, Stiff P, Wiernik PH, Winter JN, Rizzo JD, van Besien K, Lazarus HM, Vose JM. Fenske TS, et al. Among authors: hari pn. Biol Blood Marrow Transplant. 2009 Nov;15(11):1455-64. doi: 10.1016/j.bbmt.2009.07.017. Biol Blood Marrow Transplant. 2009. PMID: 19822306 Free PMC article.
Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.
Hari PN, Majhail NS, Zhang MJ, Hassebroek A, Siddiqui F, Ballen K, Bashey A, Bird J, Freytes CO, Gibson J, Hale G, Holmberg L, Kamble R, Kyle RA, Lazarus HM, LeMaistre CF, Loberiza F, Maiolino A, McCarthy PL, Milone G, Omondi N, Reece DE, Seftel M, Trigg M, Vesole D, Weiss B, Wiernik P, Lee SJ, Rizzo JD, Mehta P. Hari PN, et al. Biol Blood Marrow Transplant. 2010 Mar;16(3):395-402. doi: 10.1016/j.bbmt.2009.11.007. Epub 2009 Nov 14. Biol Blood Marrow Transplant. 2010. PMID: 19922808 Free PMC article.
334 results